CSLLY
Price
$83.82
Change
+$3.00 (+3.71%)
Updated
Jul 18 closing price
Capitalization
80.41B
SEER
Price
$2.11
Change
-$0.00 (-0.00%)
Updated
Jul 21, 10:38 AM (EDT)
Capitalization
124.17M
17 days until earnings call
Interact to see
Advertisement

CSLLY vs SEER

Header iconCSLLY vs SEER Comparison
Open Charts CSLLY vs SEERBanner chart's image
CSL
Price$83.82
Change+$3.00 (+3.71%)
Volume$74.01K
Capitalization80.41B
Seer
Price$2.11
Change-$0.00 (-0.00%)
Volume$100
Capitalization124.17M
CSLLY vs SEER Comparison Chart in %
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. SEER commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a Buy and SEER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CSLLY: $83.82 vs. SEER: $2.11)
Brand notoriety: CSLLY and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 151% vs. SEER: 33%
Market capitalization -- CSLLY: $80.41B vs. SEER: $124.17M
CSLLY [@Biotechnology] is valued at $80.41B. SEER’s [@Biotechnology] market capitalization is $124.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, CSLLY is a better buy in the long-term than SEER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 5 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • CSLLY’s TA Score: 5 bullish, 4 bearish.
  • SEER’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than SEER.

Price Growth

CSLLY (@Biotechnology) experienced а +5.95% price change this week, while SEER (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

SEER is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($80.4B) has a higher market cap than SEER($124M). CSLLY YTD gains are higher at: -3.481 vs. SEER (-8.658). CSLLY has more cash in the bank: 1.52B vs. SEER (240M). SEER has less debt than CSLLY: SEER (25.4M) vs CSLLY (12B).
CSLLYSEERCSLLY / SEER
Capitalization80.4B124M64,839%
EBITDAN/A-89.36M-
Gain YTD-3.481-8.65840%
P/E Ratio30.76N/A-
RevenueN/A15.1M-
Total Cash1.52B240M635%
Total Debt12B25.4M47,244%
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYSEER
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
49%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 7 days ago
53%
Bullish Trend 19 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
65%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
42%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
59%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBDC15.09-0.01
-0.07%
Blue Owl Capital Corp
BLK1103.59-1.79
-0.16%
Blackrock
RPID3.41-0.04
-1.16%
Rapid Micro Biosystems
CRDF4.28-0.17
-3.82%
Cardiff Oncology
OMCL26.88-1.09
-3.90%
Omnicell

CSLLY and

Correlation & Price change

A.I.dvisor tells us that CSLLY and ADAP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSLLY and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
+3.71%
ADAP - CSLLY
32%
Poorly correlated
+1.08%
MLYS - CSLLY
32%
Poorly correlated
-0.77%
CDXS - CSLLY
31%
Poorly correlated
-2.08%
SEER - CSLLY
30%
Poorly correlated
-0.47%
ADPT - CSLLY
30%
Poorly correlated
-1.05%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with PALI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
-0.47%
PALI - SEER
38%
Loosely correlated
+0.56%
DNLI - SEER
37%
Loosely correlated
-3.65%
RGNX - SEER
36%
Loosely correlated
-6.10%
KYMR - SEER
35%
Loosely correlated
-0.37%
NUVB - SEER
34%
Loosely correlated
+2.68%
More